Nakada et al. [32,33] showed that EphB2 was highly expressed in prostate cancer, gastric cancer, breast cancer, small cell lung cancer, and pancreatic cancer, but not in normal tissues. This evidence concerns the gene EPHB2 and small cell lung carcinoma.